Clinical Trials
5 trialsNCT01384513 2026-04-15
A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Phase 2 Completed
NCT06573723 2026-01-14
Institutional Registry of Rare Diseases
Hospital Italiano de Buenos Aires
Recruiting
NCT02620254 2021-02-04
Mast Cell Connect: A Registry for Patients With Mastocytosis
Blueprint Medicines Corporation
Completed
NCT03340155 2017-11-13
BioUV2017
Medical University of Graz
Phase NA Unknown
NCT00154388 2016-11-18
Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases
Novartis
Phase 2 Completed